Switching from Ustekinumab to Risankizumab Improves Outcomes in Crohn's Disease: A Single-Centre Real-World Data Analysis

被引：0
|
作者：
Qazi, U. [1 ]
Padley, J. [1 ]
Colwill, M. [1 ,2 ]
Mehta, S. [1 ]
Donovan, F. [1 ]
Alves, A. M. Francisco [1 ]
Pollok, R. [1 ,2 ]
Poullis, A. [1 ,2 ]
Patel, K. [1 ]
Honap, S. [1 ,3 ]
机构：
[1] St Georges Univ Hosp NHS Fdn Trust, Gastroenterol, London, England
[2] City St Georges Univ London, Inst Infect & Immun, London, England
[3] Kings Coll London, Sch Immunol & Microbial Sci, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1269
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1095
引用
收藏
页码：i2012 / i2012
页数：1
相关论文
共 50 条
  • [41] FEASIBILITY OF USING REAL-WORLD DATA FROM THE IMPROVECARENOW REGISTRY TO EXAMINE THE EFFICACY OF USTEKINUMAB FOR PEDIATRIC CROHN'S DISEASE
    Steiner, Steven
    Colletti, Richard B.
    King, Eileen
    Chen, Shiran
    Olano, Kelly
    Baldassano, Robert N.
    Cohen, Stanley A.
    Kappelman, Michael
    Saeed, Shehzad
    Strauss, Richard
    Volger, Sheri
    Wang, Yiting
    GASTROENTEROLOGY, 2021, 160 (06) : S560 - S561
  • [42] Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn's disease: The Scottish ustekinumab cohort
    Plevris, N.
    Robertson, A.
    Fulforth, J.
    Hall, R.
    Campbell, I.
    Kane, C.
    Veryan, J.
    Lam, W.
    Saunders, J.
    Jenkinson, P.
    Chuah, C.
    Kelly, C.
    Watts, D.
    Gaya, D.
    Macdonald, J.
    Jafferbhoy, H.
    Seenan, J. P.
    Mowat, C.
    Sutherland, D.
    Naismith, G.
    Bain, G.
    Arnott, I.
    Jones, G.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S484 - S484
  • [43] Convergent ablation for persistent atrial fibrillation: outcomes from a single-centre real-world experience
    Mannakkara, Nilanka N.
    Porter, Bradley
    Child, Nicholas
    Sidhu, Baldeep S.
    Mehta, Vishal S.
    Elliott, Mark K.
    Gould, Justin
    Ahmed, Shahada
    Razavi, Reza
    Rinaldi, Christopher A.
    Blauth, Christopher
    Gill, Jaswinder S.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 63 (01)
  • [44] Real-world outcomes of Voretigene Neparvovec: a single-centre consecutive case series
    Jalil, Assad
    Ferrara, Mariantonia
    Lippera, Myrta
    Parry, Neil
    Black, Graeme C.
    Banderas, Sandra
    Ashworth, Jane
    Biswas, Sus
    Hall, Georgina
    Gray, Jane
    Newman, William
    Ivanova, Tsveta
    EYE, 2025, : 1356 - 1363
  • [45] Effectiveness of Risankizumab in Crohn's Disease, our real-world experience: Clinical, Biochemical and Ultrasonographic responses. A single centre, observational, retrospective study
    Lozano, O. Moralejo
    Pesantes, V. C. Jarrin
    Tercero, M. Abanades
    Perez, L. Ruano
    Luque, R. Salmoral
    Rosas, C. Munoz
    Rodriguez, R. A. Gomez
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i2025 - i2026
  • [46] A real-world single-centre analysis of alemtuzumab and cladribine for multiple sclerosis
    Bose, Gauruv
    Rush, Carolina
    Atkins, Harold L.
    Freedman, Mark S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [47] Switching to TNFi versus non-TNFi biologics in Crohn's Disease patients: Real-world outcomes from a German claims data analysis
    Antolin-Fontes, B.
    Borsi, A.
    Nissinen, R.
    Bravata, I.
    Barthelmes, J. N.
    Le Bars, M.
    Lee, J.
    Maywald, U.
    Bokemeyer, B.
    Wilke, T.
    Ghiani, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S189 - S191
  • [48] Effectiveness and safety of Ustekinumab for Crohn's disease; systematic review and pooled analysis of real-world evidence
    Engel, Tal
    Yung, Diana E.
    Ma, Christopher
    Pariente, Benjamin
    Wils, Pauline
    Eliakim, Rami
    Ungar, Bella
    Ben-Horin, Shomron
    Kopylov, Uri
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (09) : 1232 - 1240
  • [49] Real-World Efficacy And Safety Of Ustekinumab And Adalimumab In Patients With Crohn's Disease: Propensity Matched Analysis
    Shin, Y.
    Hong, S. N.
    Kim, E. R.
    Chang, D. K.
    Kim, Y. H.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 842 - 842
  • [50] Effectiveness of Risankizumab in an Emirati Crohn's Disease Cohort: Real-World Insights on Induction, Maintenance, and Dose Intensification Outcomes
    Alzaabi, M. N.
    Swaid, T. K.
    Ahmed, H. A.
    Alahmed, M. A.
    Omar, N. M.
    Kumar, K. K. C.
    Ahmed, E. F.
    Malik, T. A.
    Quraishi, M. N.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1845 - i1845
12345